...
首页> 外文期刊>Scientific reports. >Laparoscopic Resection of Residual Retroperitoneal Tumor Mass in Advanced Nonseminomatous Testicular Germ Cell Tumors; a Feasible and Safe Oncological Procedure
【24h】

Laparoscopic Resection of Residual Retroperitoneal Tumor Mass in Advanced Nonseminomatous Testicular Germ Cell Tumors; a Feasible and Safe Oncological Procedure

机译:腹腔镜切除在先进的非遗传睾丸生殖细胞肿瘤中残留腹膜瘤肿瘤肿瘤;可行和安全的肿瘤学程序

获取原文

摘要

Ten-year oncological experience of the University Medical Center Groningen with conventional laparotomy (C-RRRTM) and laparoscopy (L-RRRTM) is described concerning resection of residual retroperitoneal tumor masses (RRTM) in a large series of patients with advanced nonseminomatous testicular germ cell tumors (NSTGCT). 150 consecutive patients with disseminated NSTGCT required adjunctive surgery after combination chemotherapy. L-RRRTM was scheduled in 89 and C-RRRTM in 61 patients. Median residual tumor diameter was 20?mm in the L-RRRTM versus 42?mm in the C-RRRTM group (p??0.001). Conversion rate was 15% in the L-RRRTM group. Perioperative complications occurred in 5 patients (6%) in the L-RRRTM and 7 (12%, NS) in the C-RRRTM group. Median duration of L-RRRTM was 156?minutes vs. 221?minutes for C-RRRTM (p??0.001). 17/89 patients in the L-RRRTM group had postoperative complications versus 18/61 patients in the C-RRRTM group (NS). Median postoperative stay in the L-RRRTM group was 2 vs. 6 days in the C-RRRTM group (p??0.001). During a median follow-up of 79 months, 27 patients had recurrences: 8 (9%) in the L-RRRTM group and 19 (31%) in the C-RRRTM group (p??0.001). Laparoscopic resection of RRTM for advanced NSTGCT is feasible and an oncologically safe option in appropriately selected patients.
机译:大学医疗中心Groningen的十年肿瘤经验与常规的剖腹手术(C-RRRTM)和腹腔镜检查(L-RRRTM)有关于在一系列晚期非蠕动睾丸生殖细胞的一系列患者中切除残留腹膜瘤肿瘤肿块(RRTM)肿瘤(nstgct)。 150例连续患者促进的NSTGCT在组合化疗后所需的辅助手术。 L-RRRTM于61名患者的89名和C-RRRTM安排。在C-RRTM组中,L-RRRTM中的中值残留肿瘤直径为20μmmm,在4. rRRTM组中(p?<0.001)。 L-RRRTM组转换率为15%。在C-RRRTM组的L-RRRTM和7(12%,NS)中,在5名患者(6%)中发生围手术期并发症。 L-RRRTM的中位数持续时间为156?分钟与221分钟?C-RRRTM(P?<?0.001)。 17/89患者L-RRRTM组患者对C-RRRTM组(NS)中的18/61名患者进行了术后并发症。在L-RRRTM组中位于C-RRRTM组的中位数术后,在L-RRRTM组中为2次,P?<?0.001)。在79个月的中位随访期间,27名患者在L-RRRTM组中具有复发:8(9%),C-RRRTM组19(31%)(P?<0.001)。 Laparoscopic resection of RRTM for advanced NSTGCT is feasible and an oncologically safe option in appropriately selected patients.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号